Citation Impact
Citing Papers
Benefit-Risk Assessment of Leflunomide
2009
Rheumatoid arthritis
2018 Standout
Immunosuppressants: Cellular and molecular mechanisms of action
1996
TREM and TREM-like receptors in inflammation and disease
2009 Standout
Myocardial dysfunction in the patient with sepsis
2002
Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration
2006 Standout
Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: A case report and literature review
2016
Cardiac evaluation in hypotension-prone and hypotension-resistant hemodialysis patients
1999
Leflunomide can potentiate the anticoagulant effect of warfarin
2002
Aircraft engine exhaust emissions and other airport-related contributions to ambient air pollution: A review
2014 Standout
Chronic Kidney Disease and Sudden Death: Strategies for Prevention
2004
Examination of the Risk of Continuous Leflunomide Treatment on the Incidence of Infectious Complications After Joint Arthroplasty in Patients With Rheumatoid Arthritis
2003
The Independent Association of Renal Dysfunction and Arrhythmias in Critically Ill Patients
2002
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
1999
Graves' Ophthalmopathy
2010 Standout
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Differential Modulation of Pro- and Anti-inflammatory Cytokine Receptors by N-(4-Trifluoromethylphenyl)-2-Cyano-3-Hydroxy-Crotonic Acid Amide (A77 1726), the Physiologically Active Metabolite of the Novel Immunomodulator Leflunomide
1998
Prospective, Pilot, Open-Label, Short-Term Study of Conversion to Leflunomide Reverses Chronic Renal Allograft Dysfunction
2002
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial
1999
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
2005
Ankylosing spondylitis
2007 Standout
Cardiorenal Syndrome
2008 Standout
Effects of diesel exhaust inhalation on heart rate variability in human volunteers
2008
Air pollution and health
2002 Standout
Myocardial Markers of Injury:Evolution and Insights
1996
Safety evaluation of leflunomide in rheumatoid arthritis
2013
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation
2014
Rheumatoid arthritis
2010 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Rheumatoid arthritis
2001
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Woodsmoke Health Effects: A Review
2006 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Drug Treatment for Rheumatoid Arthritis
1999
New Drugs for Rheumatoid Arthritis
2004
The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2005 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Is Daily Mortality Associated Specifically with Fine Particles?
1996
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
2013 Standout
Health Effects of Fine Particulate Air Pollution: Lines that Connect
2006 Standout
Air Pollution and Cardiovascular Disease
2004 Standout
Review of teriflunomide and its potential in the treatment of multiple sclerosis
2009
Cytokine-Induced Modulation of Cardiac Function
2004
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Review of relationship between indoor and outdoor particles: I/O ratio, infiltration factor and penetration factor
2010 Standout
Molecular and Immune Mechanisms in the Pathogenesis of Cardiomyopathy
1997
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Potential Role of Ultrafine Particles in Associations between Airborne Particle Mass and Cardiovascular Health
2005
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Fine Particulate Air Pollution and Mortality in 20 U.S. Cities, 1987–1994
2000 Standout
Prosthetic Joint Infection
2014 Standout
Modulation of the Triggering Receptor Expressed on the Myeloid Cell Type 1 Pathway in Murine Septic Shock
2006
Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.
1996
Fine particulate matter and cardiovascular disease
2000
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
2001 StandoutScienceNobel
A Case-Crossover Analysis of Particulate Matter Air Pollution and Out-of-Hospital Primary Cardiac Arrest
2001
Works of Iris Löw‐Friedrich being referenced
In vitro Approach to ‘Uremic Cardiomyopathy’
1993
Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis
1995
Effects of cytokines on the contractility of cultured cardiac myocytes
1993
Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro.
1997